Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1986-5-1
pubmed:abstractText
Of 38 patients referred with suspected cardiotoxicity after administration of antineoplastic drugs, 11 patients with signs of manifest or latent anthracycline cardiotoxicity were selected for heart catheterisation with endomyocardial biopsy. Ultrastructural abnormalities of the myocytes with myofibrillar loss and cytoplasmic vacuolation were present in most patients and these findings were more pronounced in biopsy specimens from the left ventricle. Surprisingly, light microscopy showed considerable fibrous thickening of the endocardium in 10 of 11 patients, primarily in the left ventricle. These morphological findings together with the echocardiographic and the haemodynamic data suggest that chronic anthracycline cardiotoxicity is a restrictive endomyocardial disease. The biochemical mechanisms responsible for endocardial fibrosis are unknown, but drug induced damage to the endocardium, possibly mediated via hormonal or humoral agents, may feature in the initial phase of the toxic process. The present observations contribute toward the understanding of the pathophysiology of human anthracycline cardiotoxicity.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3456785-1054099, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456785-394479, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456785-4132319, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456785-4353012, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456785-496103, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456785-53279, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456785-6167794, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456785-6387802, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456785-6452971, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456785-6637763, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456785-667859, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456785-667860, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456785-6699662, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456785-6736450, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456785-6940212, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456785-6946859, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456785-7083125, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456785-7282516, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456785-7369134, http://linkedlifedata.com/resource/pubmed/commentcorrection/3456785-939537
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0007-0769
pubmed:author
pubmed:issnType
Print
pubmed:volume
55
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
274-82
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1986
pubmed:articleTitle
Chronic anthracycline cardiotoxicity: haemodynamic and histopathological manifestations suggesting a restrictive endomyocardial disease.
pubmed:publicationType
Journal Article